Home
About
Overview
Sharing Data
ORCID
Help
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Journeycake, Janna
One or more keywords matched the following items that are connected to
Journeycake, Janna
Item Type
Name
Concept
Hemophilia A
Academic Article
Coagulation disorders.
Academic Article
Fatal central venous catheter-related infection in haemophilia.
Academic Article
Application of current knowledge to the management of bleeding events during immune tolerance induction.
Academic Article
Rituximab for treatment of inhibitors in haemophilia A. A Phase II study.
Academic Article
Extended half-life factor VIII for immune tolerance induction in haemophilia.
Academic Article
Consensus recommendations for use of central venous access devices in haemophilia.
Academic Article
Developing a multidisciplinary Young Women's Blood Disorders Program: a single-centre approach with guidance for other centres.
Academic Article
Catheter-related deep venous thrombosis in children with hemophilia.
Academic Article
Tissue plasminogen activator to prevent central venous access device infections: a systematic review of central venous access catheter thrombosis, infection and thromboprophylaxis.
Academic Article
Arthroscopic synovectomy in children and adolescents with hemophilia.
Academic Article
Implantable central venous access device procedures in haemophilia patients without an inhibitor: systematic review of the literature and institutional experience.
Academic Article
Deep venous thrombosis screening in patients with inherited bleeding disorders and central venous catheters.
Academic Article
Desmopressin (DDAVP) in the management of patients with congenital bleeding disorders.
Academic Article
PERSEPT 3: A phase 3 clinical trial to evaluate the haemostatic efficacy of eptacog beta (recombinant human FVIIa) in perioperative care in subjects with haemophilia A or B with inhibitors.
Academic Article
The safety of activated eptacog beta in the management of bleeding episodes and perioperative haemostasis in adult and paediatric haemophilia patients with inhibitors.
Academic Article
Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitors.
Search Criteria
Hemophilia B